Actualités

“CSL Behring – Core interests & collaboration opportunities”

The School of Pharmaceutical Sciences and Unitec, present: “CSL Behring – Core interests & collaboration opportunities”

CSL is a leading research-driven global biotech company that develops innovative therapies and vaccines. It is interested in exploring collaboration opportunities with UNIGE and HUG to access external innovation and to identify breakthrough technologies and novel therapeutic modalities developed in our institutions.

Join us at this event with Dr. Zuercher and Dr. Hou from CSL to hear their thoughts on potential areas for collaboration, funding opportunities to support innovative research – including the CSL 2021 Research Acceleration Initiative, how to create successful partnerships, how to connect and engage with them, what they look for... and much more.

 

page1image34823072

When: Wednesday 2 December 2020, 16:00-17:30

Where: ZOOM

Programme:

16:00 – Introduction School of Pharmaceutical Sciences (Yogeshvar Kalia)/UNITEC (Jennifer Cadby)

16:15 – Adrian Zuercher, Vice President, Research EUR & Head Plasma Protein Research: “R&D@CSL”

16:40 – Sam Hou, Director Research Bern, Therapeutic Areas: “Research External Innovation – Core Interests and Collaboration Opportunities”

17:05 – Discussion Q&A

17:25 – Wrap-up

---------------------------------------------

Participation to the event is free of charge; however, registration is mandatory.

Registration online: https://ispso.unige.ch/csl-event

Deadline for registration: Monday 30th November 2020
Registered participants will receive the zoom link to attend the meeting. For other questions: Florence.VonOw(at)unige.ch

Partners: School of Pharmaceutical sciences: https://ispso.unige.ch UNITEC: unige.ch/unitec